2023-11-29 22:42 | CC:NUMI | Numinus Wellness Inc | 0.105 | SEDAR MD & A815 | SEDAR MD & A |
2023-11-29 22:31 | CC:NUMI | Numinus Wellness Inc | 0.105 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2023-11-29 22:26 | CC:NUMI | Numinus Wellness Inc | 0.105 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-11-29 17:09 | CC:NUMI | Numinus Wellness Inc | 0.105 | News Release200 | Numinus Wellness loses $29.94-million in 2023 |
2023-11-21 13:12 | CC:NUMI | Numinus Wellness Inc | 0.11 | News Release200 | Numinus Wellness to release fiscal 2023 results Nov. 29 |
2023-10-05 18:41 | CC:NUMI | Numinus Wellness Inc | 0.165 | Prospectus Approved3 | Numinus Wellness to list additional shares on TSX |
2023-10-03 12:16 | CC:NUMI | Numinus Wellness Inc | 0.17 | News Release200 | Numinus details psychedelic program for mental distress |
2023-09-25 19:26 | CC:NUMI | Numinus Wellness Inc | 0.185 | News Release200 | Numinus arranges $10-million at-the-market program |
2023-09-19 12:02 | CC:NUMI | Numinus Wellness Inc | 0.205 | News Release200 | Numinus cheers MAPS phase 3 MDMA-AT results |
2023-09-18 19:08 | CC:NUMI | Numinus Wellness Inc | 0.225 | News Release200 | Numinus to end Numinus Bioscience operations |
2023-07-17 16:25 | CC:NUMI | Numinus Wellness Inc | | News Release200 | Numinus Wellness loses $7.29-million in Q3 2023 |
2023-07-17 16:04 | CC:NUMI | Numinus Wellness Inc | 0.245 | SEDAR MD & A815 | SEDAR MD & A |
2023-07-17 16:03 | CC:NUMI | Numinus Wellness Inc | 0.245 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-29 07:35 | CC:NUMI | Numinus Wellness Inc | 0.22 | News Release200 | Numinus Wellness to provide Q3 results July 17 |
2023-06-27 11:42 | CC:NUMI | Numinus Wellness Inc | 0.23 | SEDAR Final Short Form Prospectus810 | SEDAR Final Short Form Prospectus |
2023-06-22 07:22 | CC:NUMI | Numinus Wellness Inc | 0.26 | News Release200 | Numinus Wellness partners with HealingMaps |
2023-06-15 09:53 | CC:NUMI | Numinus Wellness Inc | 0.215 | News Release200 | Numinus partners with MAPS for clinical study |
2023-06-14 07:44 | CC:NUMI | Numinus Wellness Inc | 0.215 | News Release200 | Numinus Wellness appoints Handa as CFO |
2023-06-05 12:02 | CC:NUMI | Numinus Wellness Inc | 0.23 | News Release200 | Numinus's CCR is top enroller for MindMed's GAD study |
2023-05-30 09:31 | CC:NUMI | Numinus Wellness Inc | 0.225 | News Release200 | Numinus's CCR begins COMP360 psilocybin therapy study |
2023-05-25 09:29 | CC:NUMI | Numinus Wellness Inc | 0.15 | News Release200 | Numinus preps for future FDA approval of MDMA therapy |
2023-05-02 13:44 | CC:NUMI | Numinus Wellness Inc | 0.17 | SEDAR Preliminary Short Form Prospectus819 | SEDAR Preliminary Short Form Prospectus |
2023-04-14 07:43 | CC:NUMI | Numinus Wellness Inc | 0.19 | News Release200 | Numinus Wellness creates new client website |
2023-04-13 16:38 | CC:NUMI | Numinus Wellness Inc | 0.205 | News Release200 | Numinus loses $7.33-million in Q2 |
2023-04-13 16:08 | CC:NUMI | Numinus Wellness Inc | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
2023-04-13 16:07 | CC:NUMI | Numinus Wellness Inc | 0.22 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-04-11 10:53 | CC:NUMI | Numinus Wellness Inc | 0.22 | News Release200 | Numinus Wellness rolls out clinic licensing platform |
2023-03-30 07:50 | CC:NUMI | Numinus Wellness Inc | 0.18 | News Release200 | Numinus Wellness to provide Q2 results April 13 |
2023-03-27 10:33 | CC:NUMI | Numinus Wellness Inc | 0.18 | News Release200 | Numinus rolls out psychedelic certification training |
2023-03-21 09:51 | CC:NUMI | Numinus Wellness Inc | 0.18 | News Release200 | Numinus talks Robison's contribution on publications |
2023-02-17 09:07 | CC:NUMI | Numinus Wellness Inc | 0.245 | News Release200 | Numinus Wellness opens clinical trial site in Arizona |
2023-02-15 17:11 | CC:NUMI | Numinus Wellness Inc | 0.245 | News Release200 | Numinus Wellness shareholders approve AGM resolutions |
2023-02-01 09:31 | CC:NUMI | Numinus Wellness Inc | 0.27 | News Release200 | Numinus receives Health Canada OK for psilocybin trial |
2023-01-16 16:15 | CC:NUMI | Numinus Wellness Inc | 0.25 | News Release200 | Numinus loses $6.29-million in Q1 fiscal 2023 |
2023-01-16 16:04 | CC:NUMI | Numinus Wellness Inc | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
2023-01-16 16:03 | CC:NUMI | Numinus Wellness Inc | 0.22 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-01-04 09:52 | CC:NUMI | Numinus Wellness Inc | | News Release200 | Numinus to release fiscal Q1 2023 results Jan. 16 |
2022-12-13 20:43 | CC:NUMI | Numinus Wellness Inc | 0.20 | Warrants Expire110 | Numinus Wellness to expire Dec. 29 |
2022-12-12 20:45 | CC:NUMI | Numinus Wellness Inc | 0.215 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2022-12-08 09:43 | CC:NUMI | Numinus Wellness Inc | 0.22 | News Release200 | Numinus submits clinical trial application to HC |